Catalyst

Slingshot members are tracking this event:

Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CRME

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 09, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Xydalba, Single Dose Infusion, Approval, Ema, Dalbavancin